Physician profile
Rohan Kumar
NPI 1356186860
$606.84
in general payments reported to CMS, 2019-2025
11 companies · $459 in 2025
The $459 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $148 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $119.31 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $97.02 | 2024 | Arcalyst |
| Amgen INC. | $82.01 | 2025 | Repatha |
| Medtronic, INC. | $68.94 | 2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $50.59 | 2024 | |
| Pfizer INC. | $45.61 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.28 | 2025 | Jardiance |
| Chiesi USA, INC. | $35.03 | 2025 | Elfabrio |
| Alnylam Pharmaceuticals INC. | $30.05 | 2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $18.44 | 2025 | |
| Abbvie INC. | $14.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohan Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.